tiprankstipranks
Burning Rock Biotech Ltd. (BNR)
NASDAQ:BNR
US Market
BNR
Burning Rock Biotech
RESEARCH TOOLSreports
Want to see BNR full AI Analyst Report?

Burning Rock Biotech (BNR) Ratios

90 Followers

Burning Rock Biotech Ratios

BNR's free cash flow for Q3 2025 was ¥0.75. For the 2025 fiscal year, BNR's free cash flow was decreased by ¥ and operating cash flow was ¥-0.12. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 2.99 2.99 2.92 3.36 3.06
Quick Ratio
 2.76 2.76 2.71 3.09 2.74
Cash Ratio
 1.95 1.95 1.95 2.34 2.20
Solvency Ratio
 -0.09 -0.15 -0.97 -1.92 -1.97
Operating Cash Flow Ratio
 -0.13 -0.12 -0.35 -0.97 -1.11
Short-Term Operating Cash Flow Coverage
 -1.91 -1.68 0.00 0.00 0.00
Net Current Asset Value
¥ 453.76M¥ 453.76M¥ 472.14M¥ 612.50M¥ 829.64M
Leverage Ratios
Debt-to-Assets Ratio
 0.05 0.05 0.06 0.01 0.03
Debt-to-Equity Ratio
 0.08 0.08 0.09 0.02 0.04
Debt-to-Capital Ratio
 0.07 0.07 0.08 0.02 0.04
Long-Term Debt-to-Capital Ratio
 <0.01 <0.01 0.00 0.00 0.00
Financial Leverage Ratio
 1.53 1.53 1.52 1.35 1.37
Debt Service Coverage Ratio
 -1.63 -2.62 0.00 0.00 0.00
Interest Coverage Ratio
 -3.70K -1.83K 0.00 0.00 0.00
Debt to Market Cap
 0.15 0.12 0.00 0.00 0.00
Interest Debt Per Share
 41.20 40.03 5.08 1.20 4.89
Net Debt to EBITDA
 16.75 10.18 1.73 1.16 1.00
Profitability Margins
Gross Profit Margin
74.66%74.67%70.26%67.59%67.47%
EBIT Margin
-10.17%-10.16%-62.51%-121.19%-174.07%
EBITDA Margin
-4.87%-8.20%-52.39%-96.37%-152.03%
Operating Profit Margin
-10.17%-10.16%-69.32%-124.54%-174.07%
Pretax Profit Margin
-9.96%-9.97%-66.06%-121.19%-172.08%
Net Profit Margin
-10.25%-10.26%-67.20%-121.63%-172.44%
Continuous Operations Profit Margin
-10.25%-10.26%-67.20%-121.63%-172.44%
Net Income Per EBT
102.88%102.89%101.73%100.37%100.20%
EBT Per EBIT
98.01%98.08%95.30%97.31%98.86%
Return on Assets (ROA)
-6.72%-6.56%-39.15%-62.85%-61.18%
Return on Equity (ROE)
-9.93%-10.05%-59.68%-85.07%-83.85%
Return on Capital Employed (ROCE)
-9.53%-9.30%-57.76%-86.18%-83.37%
Return on Invested Capital (ROIC)
-9.26%-9.03%-55.56%-85.23%-80.81%
Return on Tangible Assets
-6.72%-6.56%-39.17%-62.91%-61.26%
Earnings Yield
-47.39%-35.43%-68.35%-92.83%-60.23%
Efficiency Ratios
Receivables Turnover
 2.95 2.88 2.97 3.59 3.31
Payables Turnover
 3.34 3.26 4.55 9.65 3.60
Inventory Turnover
 2.39 2.33 2.85 2.52 1.41
Fixed Asset Turnover
 7.28 7.10 5.14 3.73 1.88
Asset Turnover
 0.66 0.64 0.58 0.52 0.35
Working Capital Turnover Ratio
 1.08 1.05 0.91 0.73 0.49
Cash Conversion Cycle
 167.04 171.18 170.35 208.37 268.46
Days of Sales Outstanding
 123.54 126.58 122.73 101.61 110.32
Days of Inventory Outstanding
 152.70 156.54 127.91 144.61 259.65
Days of Payables Outstanding
 109.20 111.95 80.29 37.84 101.51
Operating Cycle
 276.24 283.13 250.64 246.22 369.96
Cash Flow Ratios
Operating Cash Flow Per Share
 -30.94 -26.37 -8.96 -24.98 -43.96
Free Cash Flow Per Share
 -36.12 -31.24 -9.54 -25.90 -49.93
CapEx Per Share
 5.17 4.87 0.58 0.92 5.97
Free Cash Flow to Operating Cash Flow
 1.17 1.18 1.06 1.04 1.14
Dividend Paid and CapEx Coverage Ratio
 -5.98 -5.42 -15.44 -27.26 -7.36
Capital Expenditure Coverage Ratio
 -5.98 -5.42 -15.44 -27.26 -7.36
Operating Cash Flow Coverage Ratio
 -0.75 -0.66 -1.76 -20.75 -8.99
Operating Cash Flow to Sales Ratio
 -0.06 -0.05 -0.18 -0.48 -0.81
Free Cash Flow Yield
-31.65%0.00%-19.37%-37.65%-32.18%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -2.22 -2.82 -1.46 -1.08 -1.66
Price-to-Sales (P/S) Ratio
 0.23 0.29 0.98 1.31 2.86
Price-to-Book (P/B) Ratio
 0.23 0.28 0.87 0.92 1.39
Price-to-Free Cash Flow (P/FCF) Ratio
 -3.33 -4.51 -5.16 -2.66 -3.11
Price-to-Operating Cash Flow Ratio
 -3.77 -5.34 -5.50 -2.75 -3.53
Price-to-Earnings Growth (PEG) Ratio
 >-0.01 -0.06 0.03 0.03 -0.07
Price-to-Fair Value
 0.23 0.28 0.87 0.92 1.39
Enterprise Value Multiple
 11.94 6.65 -0.15 -0.20 -0.89
Enterprise Value
 -318.70M -286.28M 39.60M 101.44M 757.87M
EV to EBITDA
 12.18 6.65 -0.15 -0.20 -0.89
EV to Sales
 -0.59 -0.55 0.08 0.19 1.35
EV to Free Cash Flow
 8.42 0.00 -0.40 -0.38 -1.46
EV to Operating Cash Flow
 9.83 0.00 -0.43 -0.40 -1.66
Tangible Book Value Per Share
 510.95 496.09 56.39 74.95 111.29
Shareholders’ Equity Per Share
 511.22 496.62 56.43 75.04 111.48
Tax and Other Ratios
Effective Tax Rate
 -0.03 -0.03 -0.02 >-0.01 >-0.01
Revenue Per Share
 513.34 486.66 50.11 52.49 54.20
Net Income Per Share
 -52.62 -49.92 -33.67 -63.84 -93.47
Tax Burden
 1.03 1.03 1.02 1.00 1.00
Interest Burden
 0.98 0.98 1.06 1.00 0.99
Research & Development to Revenue
 0.31 0.31 0.45 0.65 0.75
SG&A to Revenue
 0.54 0.54 0.88 0.81 1.01
Stock-Based Compensation to Revenue
 0.03 0.00 0.30 0.49 0.58
Income Quality
 0.81 0.00 0.27 0.39 0.47
Currency in CNY